Association between neutrophil-to-lymphocyte ratio and motor subtypes in idiopathic Parkinson’s disease: a prospective observational study.

Association between neutrophil-to-lymphocyte ratio and motor subtypes in idiopathic Parkinson’s disease: a prospective observational study.

Publication date: Oct 08, 2024

Peripheral immunity and neuroinflammation interact with each other and they play important roles in the pathophysiology of idiopathic Parkinson’s disease (IPD). There have been very few real-world reports on the relationship between peripheral immune inflammation and motor phenotypes of IPD. This study aimed to investigate the potential correlation between peripheral inflammatory indicators and motor subtypes in patients with IPD. This observational, prospective case-control study examined patients with IPD and healthy controls (HC) matched for age and sex between September 2021 and July 2023 at the Affiliated Huaian No. 1 People’s Hospital of Nanjing Medical University. The levels of peripheral inflammatory indicators were collected from each patient with IPD and HCs. Differences in the levels of peripheral inflammatory indicators among groups were compared. Binary logistic regression analysis was used to explore the inflammatory mechanism underlying the motor subtype of IPD. A total number of 94 patients with IPD were recruited at the Affiliated Huaian No. 1 People’s Hospital of Nanjing Medical University between September 2021 and July 2023, including 49 males and 45 females, and 37 healthy volunteers matched for age and sex were also enrolled as the control group. Of the 94 patients with IPD, 42. 6% performed as the TD motor subtype and 57. 4% performed as the AR motor subtype. NLR and the plasma levels of IL-1βand TNF-α in the IPD group were higher than those in the HC group (P 

Open Access PDF

Concepts Keywords
July IL-1β
Nanjing Inflammatory indicators
Pathophysiology Motor subtype
Volunteers NLR
Parkinson’s disease

Semantics

Type Source Name
disease MESH idiopathic Parkinson’s disease
disease MESH neuroinflammation
disease MESH inflammation
pathway REACTOME Reproduction
drug DRUGBANK Coenzyme M
disease MESH movement disorder
disease MESH neurodegenerative disease
disease MESH tremor
disease MESH pathogenesis
disease MESH tics
drug DRUGBANK L-Leucine
drug DRUGBANK Tretamine
disease MESH tumors
disease MESH cardiovascular disease
drug DRUGBANK Ethionamide
disease MESH complications
drug DRUGBANK Edetic Acid
drug DRUGBANK Levodopa
drug DRUGBANK Proline
drug DRUGBANK Esomeprazole
disease MESH oxidative stress
drug DRUGBANK Rotenone
drug DRUGBANK Trestolone
drug DRUGBANK Guanosine
disease MESH cognitive impairment
disease MESH gait
pathway KEGG Parkinson disease
disease MESH Parkinsonism
pathway REACTOME Pyroptosis
pathway REACTOME Inflammasomes
disease MESH infectious diseases
disease MESH central nervous system diseases
disease MESH hematological malignancies
disease MESH Spinocerebellar Ataxia
pathway KEGG Spinocerebellar ataxia
drug DRUGBANK (S)-Des-Me-Ampa
disease MESH Alzheimer’s Disease
drug DRUGBANK Elm
disease MESH Palsy
pathway REACTOME Metabolism
drug DRUGBANK Pentaerythritol tetranitrate
drug DRUGBANK Nitric Oxide

Original Article

(Visited 2 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *